Frequently Asked Questions

It’s normal to have questions about clinical trials, especially when deciding whether a study may be right for you. These answers are here to help you understand your options and decide what fits your needs.

Questions people often ask

Patients & Families

No. Using pRxTrialPort does not commit you to a clinical trial. You decide if and when to take any next step.

Yes. Many people use pRxTrialPort purely to understand research options, without applying to a study.

You can explore studies and use tools without sharing personal information. Identifiable details are shared only if you choose to contact a research site.

Only the research site you choose receives your contact details, and only with your consent. Sponsors never receive your name or contact information.

No. The tools are optional and designed to support reflection on understanding, confidence, and practical fit. They are not pass/fail tests.

Yes. Participation is always voluntary, and you can stop or withdraw at any time.

No. pRxTrialPort provides educational information to support understanding and decision-making. It does not replace medical advice from your healthcare team.

Community Groups

No. Hosting, maintenance, and updates are free for community organisations.

pRxTrialPort is embedded directly into your website, branded and configured for your community.

No. Communities are not asked to recruit, promote, or manage studies. The platform simply makes information visible.

No. pRxTrialPort does not share identifiable member data with community organisations.

When a member progresses through a supported pathway on a commercial study, a share of outcome-based fees is returned to the community organisation.

pRxTrialPort works with condition-specific, rare disease, and patient-led organisations that prioritise clarity, dignity, and informed choice.

Biopharma & CROs

pRxTrialPort focuses on education and readiness before recruitment. It does not sell leads or optimise for volume.

Clinical trials can be paid for by different gro

No. It complements existing workflows by improving upstream engagement quality and referral readiness.

ups, like companies that make medicine, the government, or charities.

Better informed participants, fewer unsuitable referrals, reduced site burden, and improved retention.

Sponsors receive aggregated, anonymised insights into engagement and readiness patterns. No identifiable patient data is shared.

Yes. The platform is designed to align with GDPR, HIPAA, and international privacy expectations.

Research Sites & Clinics

No. All screening and eligibility decisions remain with the research site.

Sites receive contact details and engagement context only when a person chooses to connect and provides consent.

The goal is the opposite. pRxTrialPort is designed to reduce low-quality enquiries and repetitive early-stage conversations.

No integration is required. pRxTrialPort works alongside existing site workflows.

No. Research sites are not charged to receive patient enquiries through pRxTrialPort.

Tell me more about pRxTrialPort

pRxTrialPort is a clinical research engagement platform that helps people understand clinical trials and decide whether participation makes sense for them, without pressure.

No. pRxTrialPort supports education, understanding, and readiness before recruitment begins. It does not sell leads or push people into studies.

pRxTrialPort is free for patients and community organisations. Commercial partners fund the platform.

Biopharma sponsors pay for activation, engagement support, and outcomes. Fees are aligned to meaningful progress, not clicks or volume.

Information is retrieved from public registries such as ClinicalTrials.gov and refreshed monthly. For commercially supported studies, patient information sheets and eligibility criteria may also be processed to create clearer summaries.

Yes. pRxTrialPort aligns with HIPAA, GDPR and local privacy requirements. Patients retain full control of their information and can review our data protection position statement for more details.

AI is used to generate plain language summaries from publicly available registry data and, for some studies, to process eligibility criteria and patient information sheets. Uploaded documents are stored for 30 days or less and then deleted. Our AI usage follows established regulatory frameworks and ethical guidelines.

Most platforms focus only on eligibility and location. pRxTrialPort combines medical suitability with behavioural science and mental fitness assessments to support informed decisions and better retention. Our commercial model is based on engagement, not just leads, aligning our success with patient follow-through.